Provided By PR Newswire
Last update: May 12, 2025
NEW YORK, May 12, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ: ALDX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read more at prnewswire.comNASDAQ:ALDX (12/5/2025, 1:31:40 PM)
4.77
-0.11 (-2.25%)
Find more stocks in the Stock Screener


